May 8, 2018


The "Pill of Tomorrow, Here Today"


Currently, medication non-adherence costs more and affects more people than any single disease.  Approximately 70% of American adults suffer from at least one chronic disease and ~50% of medications for chronic disease are not taken as prescribed[1], and hence the U.S. suffers significant associated costs, both in terms of dollars and lives.

These costs are estimated to amount to $100-$289 billion of avoidable spend and more than 125,000+ deaths per year resulting from medication non-adherence[2]

Lyndra's solution

Lyndra is making daily pills a thing of the past. 

Instead of having to take medications daily or more frequently, Lyndra’s oral, ultra-long-acting, sustained-release therapies, could allow patients to take medication weekly, or even monthly. The aim is to improve medication adherence, health outcomes, and help lower the cost of care.


Lyndra’s near-term focus is on addressing health conditions where therapeutic need is largely unmet and where patient non-adherence has been well documented to adversely affect health outcomes. The current pipeline includes therapies for Alzheimer’s disease, HIV, opioid use disorder and schizophrenia as well as a new once-monthly option for oral contraception.

Latest News

REFERENCES : [1] [2] Rosenbaum, L., Shrank, W. (2013).The NEJM 369(8), 694-695.